703 related articles for article (PubMed ID: 26084935)
21. [Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units].
Campistol J; González MJ; Gutiérrez AP; Vilaseca MA;
Med Clin (Barc); 2012 Mar; 138(5):185-91. PubMed ID: 21794880
[TBL] [Abstract][Full Text] [Related]
22. One-year follow-up of B vitamin and Iron status in patients with phenylketonuria provided tetrahydrobiopterin (BH4).
Brantley KD; Douglas TD; Singh RH
Orphanet J Rare Dis; 2018 Oct; 13(1):192. PubMed ID: 30373601
[TBL] [Abstract][Full Text] [Related]
23. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
24. The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study.
Olofsson S; Gralén K; Hoxer C; Okhuoya P; Persson U
Eur J Health Econ; 2022 Aug; 23(6):993-1005. PubMed ID: 34842989
[TBL] [Abstract][Full Text] [Related]
25. Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study.
Klimek A; Baerwald C; Schwarz M; Rutsch F; Parhofer KG; Plöckinger U; Heddrich-Ellerbrok M; Vom Dahl S; Schöne K; Ott M; Lang F; Hennermann JB
Ann Nutr Metab; 2020; 76(4):251-258. PubMed ID: 32998147
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
[TBL] [Abstract][Full Text] [Related]
27. Quality of life and associated factors in parents of children with late diagnosed phenylketonuria. A cross sectional study in a developing country (Tunisia).
Ben Abdelaziz R; Ben Chehida A; Kachouri H; Ben Messaoud S; Ferchichi M; Ben Ameur Z; Sassi Y; Abdelmoula MS; Azzouz H; Tebib N
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):901-913. PubMed ID: 32639944
[TBL] [Abstract][Full Text] [Related]
28. Adaptation and Validation of a Questionnaire to Evaluate Knowledge of the Low Phe Diet in PKU.
Ramos-Álvarez R; Kapp M; Rodríguez-Ruiz MM; Fausor R; Bueno-Delgado MA; Ahring K; Waisbren SE
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444879
[TBL] [Abstract][Full Text] [Related]
29. Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence.
Enns GM; Koch R; Brumm V; Blakely E; Suter R; Jurecki E
Mol Genet Metab; 2010; 101(2-3):99-109. PubMed ID: 20678948
[TBL] [Abstract][Full Text] [Related]
30. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
31. Caregiver Quality of Life with Tyrosinemia Type 1.
Campbell H; Singh RH; Hall E; Ali N
J Genet Couns; 2018 Jun; 27(3):723-731. PubMed ID: 29110168
[TBL] [Abstract][Full Text] [Related]
32. "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial.
Ten Hoedt AE; Hollak CE; Boelen CC; van der Herberg-van de Wetering NA; Ter Horst NM; Jonkers CF; Wijburg FA; Bosch AM
Orphanet J Rare Dis; 2011 Jun; 6():48. PubMed ID: 21708003
[TBL] [Abstract][Full Text] [Related]
33. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
[TBL] [Abstract][Full Text] [Related]
34. Screening for cognitive and social-emotional problems in individuals with PKU: tools for use in the metabolic clinic.
Waisbren S; White DA
Mol Genet Metab; 2010; 99 Suppl 1():S96-9. PubMed ID: 20123479
[TBL] [Abstract][Full Text] [Related]
35. Psychological wellbeing in parents of children with phenylketonuria and association with treatment adherence.
Borghi L; Salvatici E; Banderali G; Riva E; Giovannini M; Vegni E
Minerva Pediatr (Torino); 2021 Aug; 73(4):330-339. PubMed ID: 29651832
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in Spanish coeliac children using the generic KIDSCREEN-52 questionnaire.
Barrio J; Cilleruelo ML; Román E; Fernández C
Eur J Pediatr; 2018 Oct; 177(10):1515-1522. PubMed ID: 30014304
[TBL] [Abstract][Full Text] [Related]
37. Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal.
Landolt MA; Nuoffer JM; Steinmann B; Superti-Furga A
J Pediatr; 2002 May; 140(5):516-21. PubMed ID: 12032515
[TBL] [Abstract][Full Text] [Related]
38. Carbohydrate status in patients with phenylketonuria.
Couce ML; Sánchez-Pintos P; Vitoria I; De Castro MJ; Aldámiz-Echevarría L; Correcher P; Fernández-Marmiesse A; Roca I; Hermida A; Martínez-Olmos M; Leis R
Orphanet J Rare Dis; 2018 Jun; 13(1):103. PubMed ID: 29945661
[TBL] [Abstract][Full Text] [Related]
39. The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.
Bosch AM; Tybout W; van Spronsen FJ; de Valk HW; Wijburg FA; Grootenhuis MA
J Inherit Metab Dis; 2007 Feb; 30(1):29-34. PubMed ID: 17160615
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
